Ventricular Assist Device
7
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
A Safety and Effectiveness Study of the Supira System in Patients Undergoing HRPCI - CE Study
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Low Psoas Index and Cardiac Assistance: No Excess Mortality at D28 Post Implantation
Ventricular Assist Device (VAD) Infection Prevention Survey
Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3
Improved Self-management for Patients on Ventricular Assist Device (VAD)
Influence of Telemonitoring on the Management of LVAD-patients